Firefly Neuroscience, Inc. (AIFF)

CA — Technology Sector
Peers:

Automate Your Wheel Strategy on AIFF

With Tiblio's Option Bot, you can configure your own wheel strategy including AIFF - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol AIFF
  • Rev/Share 0.4668
  • Book/Share -0.0448
  • PB -70.0535
  • Debt/Equity -1.8507
  • CurrentRatio 0.5281
  • ROIC -26.9704

 

  • MktCap 40383854.0
  • FreeCF/Share -0.8782
  • PFCF -5.4964
  • PE -2.8749
  • Debt/Assets 0.1508
  • DivYield 0
  • ROE -6.6594

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 2
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
AIFF
Published: May 05, 2025 by: GlobeNewsWire
Sentiment: Neutral

A correction from source is being issued with respect to the press release titled, Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc., released on May 5, 2025 at 8:00 am ET. Please note, the correct form of payment of the potential Evoke investors' earn-out is in Firefly's common stock. The complete corrected press release follows:

Read More
image for news Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
AIFF
Published: February 21, 2025 by: GlobeNewsWire
Sentiment: Neutral

Extends cash runway well into mid-2026; no new/replacement warrants issued Extends cash runway well into mid-2026; no new/replacement warrants issued

Read More
image for news Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
Firefly Neuroscience Accepted into NVIDIA Connect Program
AIFF
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral

Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform

Read More
image for news Firefly Neuroscience Accepted into NVIDIA Connect Program

About Firefly Neuroscience, Inc. (AIFF)

  • IPO Date 2002-11-28
  • Website https://fireflyneuro.com
  • Industry Software - Application
  • CEO Mr. Greg Lipschitz
  • Employees 13
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.